TY  - GEN
AU  - Li,Xing
AU  - Lin,Qu
AU  - Dong,Min
AU  - Wen,Jing-Yun
AU  - Wei,Li
AU  - Ma,Xiao-Kun
AU  - Chen,Zhan-Hong
AU  - Wu,Xiang-Yuan
TI  - Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma
SN  - 1029-2403
PY  - 2010///1221
KW  - Acute Disease
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Antiviral Agents
KW  - therapeutic use
KW  - Bilirubin
KW  - metabolism
KW  - Cyclophosphamide
KW  - DNA, Viral
KW  - genetics
KW  - Doxorubicin
KW  - Female
KW  - Follow-Up Studies
KW  - Hepatitis B
KW  - drug therapy
KW  - Hepatitis B virus
KW  - physiology
KW  - Humans
KW  - Liver Function Tests
KW  - Lymphoma, B-Cell, Marginal Zone
KW  - virology
KW  - Lymphoma, Follicular
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - Male
KW  - Middle Aged
KW  - Polymerase Chain Reaction
KW  - Prednisone
KW  - Prognosis
KW  - Prothrombin Time
KW  - Rituximab
KW  - Survival Rate
KW  - Vincristine
KW  - Virus Activation
KW  - drug effects
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3109/10428194.2010.499486
ER  -